AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...

Two current and two former senior executives at AstraZeneca Plc are under investigation in China in an ongoing probe into ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

The 58-acre site at Tuas South will be the first of its kind for the company to produce cancer medicines. Read more at straitstimes.com.

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former executives of the company.

Barclays analyst Emily Field says the selloff yesterday in shares of AstraZeneca (AZN) on a local news report that China’s investigation ...

Deutsche Bank upgraded AstraZeneca (AZN) to Hold from Sell with an unchanged price target of 10,500 GBp. The firm cites valuation for the ...